OTCM
MDXL
Market cap20kUSD
Nov 03, Last price
0.00USD
Name
Medixall Group Inc
Chart & Performance
P/E
—
P/S
0.35
EPS
—
Div Yield, %
—
Shrs. gr., 5y
16.82%
Rev. gr., 5y
21.67%
Revenues
59k
+295.25%
Net income
-7m
L+13.18%
CFO
-4m
L-23.99%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MediXall Group, Inc., together with its subsidiaries, develops and operates a healthcare marketplace platform to help consumers learn, decide, and pay for healthcare in ways that complement relationships with trusted doctors in the United States. The company offers Health Karma platform that provides medical and wellness services to individuals, employer groups, and third-party administrators. MediXall Group, Inc. was incorporated in 1998 and is based in Fort Lauderdale, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||